INNOVADERM CRO IS NOW INDERO.

Our Insights

FILTER BY:

FILTER BY:

News

Innovaderm Honoured With a CRO Leadership Award Again This Year

News

Innovaderm manages a study in PPP and beats recruitment timelines

News

Clinical research unit design – Platinum Winner – Grand Prix du Design

News

Innovaderm receives top recognition in the CRO Leadership Awards

News

Innovaderm accredited on rave EDC

News

Collaboration – Dermatology Decentralized Clinical Trials

News

Innovaderm Welcomes its New Vice-President, Biometrics

News

Advancing the Development of Imsidolimab with AnaptysBio

News

Innovaderm Moves its Clinical Research Unit Into its new State-of-the-Art Facility

FILTER BY:

patient centricity in rheumatoid arthritis clinical trials
Post

Patient-Centric Approaches to Managing Rheumatoid Arthritis Trials

clinical trials strategy
Post

Strategies for Global Clinical Trials: Timelines, Communication, and Resilience

rater training clinical trials
Post

Ensuring Consistency: The Impact of Rater Training in Clinical Trials

Solving the Challenges of Patient Recruitment
Post

Solving the Challenges of Patient Recruitment

Setting Your Sites on Successful Clinical Trials
Post

Setting Your Sites on Successful Clinical Trials

Putting Patients First in Clinical Trial
Post

Putting Patients First in Clinical Trials

The Key to a Successful Clinical Trial
Post

The Key to a Successful Clinical Trial

Improving Patient Recruitment in Clinical Trials
Post

Improving Patient Recruitment in Clinical Trials

Embracing the Power of Data Analytics and AI for Clinical Trials
Post

Embracing the Power of Data Analytics and AI for Clinical Trials

FILTER BY:

FILTER BY:

FILTER BY:

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.